THE PENNANT GROUP, INC. Business Acquisition, Pro Forma Net Income (Loss)
THE PENNANT GROUP, INC. (PNTG) reported Business Acquisition, Pro Forma Net Income (Loss) of $4.75 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-11-07
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for the quarter ending 2022-09-30 was $4.75M, a 315.66% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for the quarter ending 2021-09-30 was $1.14M, a 74.37% decline year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for the quarter ending 2020-12-31 was $1.90M.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for the quarter ending 2020-09-30 was $4.46M, a 224.29% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for fiscal 2020 was $13.78M, a 979.40% increase from fiscal 2019.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for fiscal 2019 was $1.28M, a 92.35% decline from fiscal 2018.
- THE PENNANT GROUP, INC. business acquisition, pro forma net income (loss) for fiscal 2018 was $16.69M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | $4.75M 10-Q · filed 2022-11-07 | $2.37M 10-Q · filed 2022-11-07 | |||||
| 2021-09-30 | $1.14M 10-Q · filed 2022-11-07 | $4.56M 10-Q · filed 2022-11-07 | |||||
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $6.36M derived: sum of 2 quarters · filed 2021-02-24 | $13.78M 10-K · filed 2021-02-24 | ||||
| 2020-09-30 | $4.46M 10-Q · filed 2020-11-10 | $11.88M 10-Q · filed 2020-11-10 | |||||
| 2019-12-31 | -$4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$3.53M derived: sum of 2 quarters · filed 2021-02-24 | $1.28M 10-K · filed 2021-02-24 | $2.96M 10-K · filed 2020-03-04 | |||
| 2019-09-30 | $1.38M 10-Q · filed 2020-11-10 | $1.53M 10-Q · filed 2019-11-12 | $6.18M 10-Q · filed 2020-11-10 | $6.95M 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $8.03M derived: sum of 2 quarters · filed 2020-03-04 | $16.69M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $4.93M 10-Q · filed 2019-11-12 | $13.59M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |